Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats

  • Authors:
    • Dongmin Xu
    • Li Li
    • Leilei Tang
    • Ming Guo
    • Jie Yang
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, Chun'an First People's Hospital, Zhejiang Province People's Hospital Chun'an Branch, Hangzhou, Zhejiang 311700, P.R. China, Department of Pharmacy, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang 311200, P.R. China, Department of Cardiology, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang 311200, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 14
    |
    Published online on: October 28, 2021
       https://doi.org/10.3892/etm.2021.10936
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Perfluorooctane sulfonate (PFOS) is a persistent pollutant that exerts toxicity and induces cardiogenesis in humans and animals. Yet, the effect of PFOS exposure on cardiac toxicity in adult rats has, to our knowledge, not been reported and the mechanism still remains unknown. The present study aimed to investigate the toxicity of PFOS on rat hearts and any associated mechanisms. Rats were exposed to 0 (control), 1 and 10 mg/kg PFOS every other day for 14 days. Body weight and heart weight were recorded. The serum levels of lactic dehydrogenase (LDH), creatine kinase (CK), creatine kinase‑isoenzyme‑MB (CK‑MB) and cardiac troponin‑T (cTn‑T) in heart tissues were measured using biochemical assays. TUNEL staining and western blotting were applied to analyze levels of apoptosis in rat hearts. Pathological assessment and immunohistochemistry analysis of heart tissues were used to evaluate the levels of PFOS‑induced cardiotoxicity and inflammatory infiltration. PFOS exposure at the dosage of 10 mg/kg significantly increased the percentage of heart to body weight; however, it did not alter the body weight. At 10 mg/kg, PFOS significantly increased expression levels of myocardial injury markers, such as cTn‑T, LDH, CK and CK‑MB, while 1 mg/kg PFOS upregulated the expression level of cTn‑T in rats. Notably, cardiac fibrosis and myocardiac hypertrophy appeared in the 10 mg/kg PFOS group. In addition, TUNEL‑positive cells were significantly increased by exposure to 10 mg/kg PFOS in rat heart tissues. The protein expressions profiles of p53 and Bax were also significantly upregulated in the 10 mg/kg PFOS group. Inflammatory infiltration, detected by anaylzing expression levels of IL‑1β and TNF‑α, was significantly raised by 10 mg/kg PFOS exposure. In conclusion, these results demonstrated that 10 mg/kg PFOS‑induced cardiac toxicity in rats, which was associated with an increase in apoptosis and the expression of proinflammatory cytokines.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Wang G, Sun S, Wu X, Yang S, Wu Y, Zhao J, Zhang H and Chen W: Intestinal environmental disorders associate with the tissue damages induced by perfluorooctane sulfonate exposure. Ecotoxicol Environ Saf. 197(110590)2020.PubMed/NCBI View Article : Google Scholar

2 

Gao Y, Guo X, Wang S, Chen F, Ren X, Xiao H and Wang L: Perfluorooctane sulfonate enhances mRNA expression of PPARγ and ap2 in human mesenchymal stem cells monitored by long-retained intracellular nanosensor. Environ Pollut. 263(114571)2020.PubMed/NCBI View Article : Google Scholar

3 

Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL and Zobel LR: Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 115:1298–1305. 2007.PubMed/NCBI View Article : Google Scholar

4 

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL and Stevenson LA: Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci. 74:382–392. 2003.PubMed/NCBI View Article : Google Scholar

5 

UNEP: The stockholm convention-national implementation plans-addressing COP 4 amendments. http://chm.pops.int/Implementation/NIPs/NIPTransmission/tabid/253/Default.aspx. (accessed on September 7th 2019), 2016.

6 

Xie S, Wang T, Liu S, Jones KC, Sweetman AJ and Lu Y: Industrial source identification and emission estimation of perfluorooctane sulfonate in China. Environ Int. 52:1–8. 2013.PubMed/NCBI View Article : Google Scholar

7 

Wang S, Huang J, Yang Y, Hui Y, Ge Y, Larssen T, Yu G, Deng S, Wang B and Harman C: First report of a Chinese PFOS alternative overlooked for 30 years: Its toxicity, persistence, and presence in the environment. Environ Sci Technol. 47:10163–10170. 2013.PubMed/NCBI View Article : Google Scholar

8 

Jin H, Lin S, Dai W, Feng L, Li T, Lou J and Zhang Q: Exposure sources of perfluoroalkyl acids and influence of age and gender on concentrations of chlorinated polyfluorinated ether sulfonates in human serum from China. Environ Int. 138(105651)2020.PubMed/NCBI View Article : Google Scholar

9 

Huang Q, Fang C, Wu X, Fan J and Dong S: Perfluorooctane sulfonate impairs the cardiac development of a marine medaka (Oryzias melastigma). Aquat Toxicol. 105:71–77. 2011.PubMed/NCBI View Article : Google Scholar

10 

Chan E, Burstyn I, Cherry N, Bamforth F and Martin JW: Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res. 111:559–564. 2011.PubMed/NCBI View Article : Google Scholar

11 

Elcombe CR, Elcombe BM, Foster JR, Chang SC, Ehresman DJ and Butenhoff JL: Hepatocellular hypertrophy and cell proliferation in sprague-dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. Toxicology. 293:16–29. 2012.PubMed/NCBI View Article : Google Scholar

12 

Yang L, He L, Xue J, Ma Y, Xie Z, Wu L, Huang M and Zhang Z: Persulfate-based degradation of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in aqueous solution: Review on influences, mechanisms and prospective. J Hazard Mater. 393(122405)2020.PubMed/NCBI View Article : Google Scholar

13 

Zhang YY, Tang LL, Zheng B, Ge RS and Zhu DY: Protein profiles of cardiomyocyte differentiation in murine embryonic stem cells exposed to perfluorooctane sulfonate. J Appl Toxicol. 36:726–740. 2016.PubMed/NCBI View Article : Google Scholar

14 

Cheng W, Yu Z, Feng L and Wang Y: Perfluorooctane sulfonate (PFOS) induced embryotoxicity and disruption of cardiogenesis. Toxicol In Vitro. 27:1503–1512. 2013.PubMed/NCBI View Article : Google Scholar

15 

Xia W, Wan Y, Li YY, Zeng H, Lv Z, Li G, Wei Z and Xu SQ: PFOS prenatal exposure induce mitochondrial injury and gene expression change in hearts of weaned SD rats. Toxicology. 282:23–29. 2011.PubMed/NCBI View Article : Google Scholar

16 

Dong Y, Chen H, Gao J, Liu Y, Li J and Wang J: Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol. 136:27–41. 2019.PubMed/NCBI View Article : Google Scholar

17 

Tomei LD and Umansky SR: Apoptosis and the heart: A brief review. Ann N Y Acad Sci. 946:160–168. 2001.PubMed/NCBI View Article : Google Scholar

18 

Zeng HC, He QZ, Li YY, Wu CQ, Wu YM and Xu SQ: Prenatal exposure to PFOS caused mitochondia-mediated apoptosis in heart of weaned rat. Environ Toxicol. 30:1082–1090. 2015.PubMed/NCBI View Article : Google Scholar

19 

Zhang Y, Beesoon S, Zhu L and Martin JW: Isomers of perfluorooctanesulfonate and perfluorooctanoate and total perfluoroalkyl acids in human serum from two cities in North China. Environ Int. 53:9–17. 2013.PubMed/NCBI View Article : Google Scholar

20 

Shi X, Du Y, Lam PK, Wu RS and Zhou B: Developmental toxicity and alteration of gene expression in zebrafish embryos exposed to PFOS. Toxicol Appl Pharmacol. 230:23–32. 2008.PubMed/NCBI View Article : Google Scholar

21 

Shi X and Zhou B: The role of Nrf2 and MAPK pathways in PFOS-induced oxidative stress in zebrafish embryos. Toxicol Sci. 15:391–400. 2010.PubMed/NCBI View Article : Google Scholar

22 

Han R, Zhang F, Wan C, Liu L, Zhong Q and Ding W: Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB/TNF-α/IL-6-dependent pathway. Chemosphere. 200:283–294. 2018.PubMed/NCBI View Article : Google Scholar

23 

National Research Council: Guide for the Care and Use of Laboratory Animals: Eighth Edition. The National Academies Press, Washington, DC, 2011.

24 

Chou HC, Wen LL, Chang CC, Lin CY, Jin L and Juan SH: From the cover: l-carnitine via PPARγ- and sirt1-dependent mechanisms attenuates epithelial-mesenchymal transition and renal fibrosis caused by perfluorooctanesulfonate. Toxicol Sci. 160:217–229. 2017.PubMed/NCBI View Article : Google Scholar

25 

Wen LL, Lin CY, Chou HC, Chang CC, Lo HY and Juan SH: Perfluorooctanesulfonate mediates renal tubular cell apoptosis through PPARgamma inactivation. PLoS One. 11(e0155190)2016.PubMed/NCBI View Article : Google Scholar

26 

Zhang L, Duan X, Sun W and Sun H: Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway. Sci Total Environ. 726(138498)2020.PubMed/NCBI View Article : Google Scholar

27 

Calafat AM, Wong LY, Kuklenyik Z, Reidy JA and Needham LL: Polyfluoroalkyl chemicals in the U.S. population: Data from the national health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 115:1596–1602. 2007.PubMed/NCBI View Article : Google Scholar

28 

Yan G: Environmental behavior and human exposure to perfluoroalkyl acids around a manufacturing facility in China. Graduate University of the Chinese Academy of Sciences, 2017.

29 

3M: Perfluorooctane Sulfonate: Current Summary of Human Sera, Health and Toxicology Data. 1st edition. U.S. Environmental Protection Agency, St. Paul, MN, pp1-129, 1999.

30 

Harada K, Xu F, Ono K, Iijima T and Koizumi A: Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. Biochem Biophys Res Commun. 329:487–494. 2005.PubMed/NCBI View Article : Google Scholar

31 

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA and Lau C: Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci. 74:369–381. 2003.PubMed/NCBI View Article : Google Scholar

32 

Huang H, Huang C, Wang L, Ye X, Bai C, Simonich MT, Tanguay RL and Dong Q: Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS). Aquat Toxicol. 98:139–147. 2010.PubMed/NCBI View Article : Google Scholar

33 

Tang LL, Wang JD, Xu TT, Zhao Z, Zheng JJ, Ge RS and Zhu DY: Mitochondrial toxicity of perfluorooctane sulfonate in mouse embryonic stem cell-derived cardiomyocytes. Toxicology. 382:108–116. 2017.PubMed/NCBI View Article : Google Scholar

34 

Xu M, Liu G, Li M, Huo M, Zong W and Liu R: Probing the cell apoptosis pathway induced by perfluorooctanoic acid and perfluorooctane sulfonate at the subcellular and molecular levels. J Agric Food Chem. 68:633–641. 2020.PubMed/NCBI View Article : Google Scholar

35 

Zhang L, Li YY, Zeng HC, Li M, Wan YJ, Schluesener HJ, Zhang ZY and Xu SQ: Perfluorooctane sulfonate induces apoptosis in N9 microglial cell line. Int J Toxicol. 30:207–215. 2011.PubMed/NCBI View Article : Google Scholar

36 

Hu XZ and Hu DC: Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Arch Toxicol. 83:851–861. 2009.PubMed/NCBI View Article : Google Scholar

37 

Kim HS, Jun Kwack S, Sik Han E, Seok Kang T, Hee Kim S and Young Han S: Induction of apoptosis and CYP4A1 expression in sprague-dawley rats exposed to low doses of perfluorooctane sulfonate. J Toxicol Sci. 36:201–210. 2011.PubMed/NCBI View Article : Google Scholar

38 

Shen Y and White E: p53-dependent apoptosis pathways. Adv Cancer Res. 82:55–84. 2001.PubMed/NCBI View Article : Google Scholar

39 

Fang X, Zou S, Zhao Y, Cui R, Zhang W, Hu J and Dai J: Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines. Arch Toxicol. 86:1515–1525. 2012.PubMed/NCBI View Article : Google Scholar

40 

Xu Y, Li Y, Scott K, Lindh CH, Jakobsson K, Fletcher T, Ohlsson B and Andersson EM: Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environ Res. 181(108923)2020.PubMed/NCBI View Article : Google Scholar

41 

Qiu Z, Qu K, Luan F, Liu Y, Zhu Y, Yuan Y, Li H, Zhang H, Hai Y and Zhao C: Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison. Environ Int. 134(105284)2020.PubMed/NCBI View Article : Google Scholar

42 

Xu C, Jiang ZY, Liu Q, Liu H and Gu AH: Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse. Environ Sci Pollut Res Int. 24:13414–13423. 2017.PubMed/NCBI View Article : Google Scholar

43 

Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS and Keil DE: Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 104:144–154. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu D, Li L, Tang L, Guo M and Yang J: Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats. Exp Ther Med 23: 14, 2022.
APA
Xu, D., Li, L., Tang, L., Guo, M., & Yang, J. (2022). Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats. Experimental and Therapeutic Medicine, 23, 14. https://doi.org/10.3892/etm.2021.10936
MLA
Xu, D., Li, L., Tang, L., Guo, M., Yang, J."Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats". Experimental and Therapeutic Medicine 23.1 (2022): 14.
Chicago
Xu, D., Li, L., Tang, L., Guo, M., Yang, J."Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats". Experimental and Therapeutic Medicine 23, no. 1 (2022): 14. https://doi.org/10.3892/etm.2021.10936
Copy and paste a formatted citation
x
Spandidos Publications style
Xu D, Li L, Tang L, Guo M and Yang J: Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats. Exp Ther Med 23: 14, 2022.
APA
Xu, D., Li, L., Tang, L., Guo, M., & Yang, J. (2022). Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats. Experimental and Therapeutic Medicine, 23, 14. https://doi.org/10.3892/etm.2021.10936
MLA
Xu, D., Li, L., Tang, L., Guo, M., Yang, J."Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats". Experimental and Therapeutic Medicine 23.1 (2022): 14.
Chicago
Xu, D., Li, L., Tang, L., Guo, M., Yang, J."Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats". Experimental and Therapeutic Medicine 23, no. 1 (2022): 14. https://doi.org/10.3892/etm.2021.10936
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team